In vivo toxicology testing is used to understand the biological response of individual body to toxin exposure. In vivo toxicology assists in minimizing the adverse effects of molecules within the body, during the development process of new drugs. Animals are used to test the toxicity of chemicals. In vivo toxicology is also used to test the response of the immune system to toxic substances like industrial and environmental chemicals.
MARKET DYNAMICS
Stringent animal testing regulations, rise in pharmaceutical and oncology research and development activities, rising focus on personalized medicine, and innovations in animal models are few of the factors driving the global in vivo toxicology market. Furthermore, the technological advancements in vivo toxicology tests will also further drive the global in vivo toxicology market. However, loopholes in animal testing and growing demand to undertake substitute animal testing methods are few of the factors may restrain the growth of global in vivo toxicology market.
The number of clinical trials are growing. For instance, according to the ClinicalTrials.gov, a total of 281,305 studies are registered on their database as of August 2021.
MARKET SCOPE
The "Global In Vivo Toxicology Market Analysis to 2031" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of In Vivo Toxicology market with detailed market segmentation by product, testing type, toxicity endpoint and geography. The global In Vivo Toxicology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading In Vivo Toxicology market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global In Vivo Toxicology market is segmented on the basis of product, testing type, and toxicity endpoint. Based on products, the market is segmented as instruments, animal models, and reagents & kits. Animal models segment is further divided into mice model, rat model and other animal model. On the basis of testing type, the global In Vivo Toxicology market is segmented into chronic toxicity testing, sub-chronic toxicity testing, sub-acute toxicity testing, and acute toxicity testing. Based on toxicity endpoint, the market is segmented into immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, developmental and reproductive toxicity (DART).
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global In Vivo Toxicology market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The In Vivo Toxicology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting In Vivo Toxicology market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the In Vivo Toxicology market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global In Vivo Toxicology market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The In Vivo Toxicology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting In Vivo Toxicology market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the In Vivo Toxicology market in these regions.
MARKET PLAYERSThe reports cover key developments in the In Vivo Toxicology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from In Vivo Toxicology market are anticipated to lucrative growth opportunities in the future with the rising demand for In Vivo Toxicology in the global market. Below mentioned is the list of few companies engaged in the In Vivo Toxicology market.
The report also includes the profiles of key In Vivo Toxicology market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Thermo Fisher Scientific
- Danaher
- Charles River Laboratories
- Labcorp
- The Jackson Laboratory
- Data Sciences International
- Envigo
- Eurofins Scientific
- Perkinelmer
- SRI International
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 In Vivo Toxicology Market - By Product
1.3.2 In Vivo Toxicology Market - By Testing type
1.3.3 In Vivo Toxicology Market - By Toxicity endpoint
1.3.4 In Vivo Toxicology Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. IN VIVO TOXICOLOGY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. IN VIVO TOXICOLOGY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. IN VIVO TOXICOLOGY MARKET - GLOBAL MARKET ANALYSIS
6.1. IN VIVO TOXICOLOGY - GLOBAL MARKET OVERVIEW
6.2. IN VIVO TOXICOLOGY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. IN VIVO TOXICOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. ANIMAL MODELS
7.4.1. Overview
7.4.2. Animal models Market Forecast and Analysis
7.4.3. Mice model Market
7.4.3.1. Overview
7.4.3.2. Mice model Market Forecast and Analysis
7.4.4. Rat model Market
7.4.4.1. Overview
7.4.4.2. Rat model Market Forecast and Analysis
7.4.5. Other animal model Market
7.4.5.1. Overview
7.4.5.2. Other animal model Market Forecast and Analysis
7.5. REAGENTS AND KITS
7.5.1. Overview
7.5.2. Reagents and kits Market Forecast and Analysis
8. IN VIVO TOXICOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - TESTING TYPE
8.1. OVERVIEW
8.2. TESTING TYPE MARKET FORECASTS AND ANALYSIS
8.3. CHRONIC TOXICITY TESTING
8.3.1. Overview
8.3.2. Chronic toxicity testing Market Forecast and Analysis
8.4. SUB-CHRONIC TOXICITY TESTING
8.4.1. Overview
8.4.2. Sub-chronic toxicity testing Market Forecast and Analysis
8.5. SUB-ACUTE TOXICITY TESTING
8.5.1. Overview
8.5.2. Sub-acute toxicity testing Market Forecast and Analysis
8.6. ACUTE TOXICITY TESTING
8.6.1. Overview
8.6.2. Acute toxicity testing Market Forecast and Analysis
9. IN VIVO TOXICOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - TOXICITY ENDPOINT
9.1. OVERVIEW
9.2. TOXICITY ENDPOINT MARKET FORECASTS AND ANALYSIS
9.3. IMMUNOTOXICITY
9.3.1. Overview
9.3.2. Immunotoxicity Market Forecast and Analysis
9.4. SYSTEMIC TOXICITY
9.4.1. Overview
9.4.2. Systemic toxicity Market Forecast and Analysis
9.5. CARCINOGENICITY
9.5.1. Overview
9.5.2. Carcinogenicity Market Forecast and Analysis
9.6. GENOTOXICITY
9.6.1. Overview
9.6.2. Genotoxicity Market Forecast and Analysis
9.7. DEVELOPMENTAL AND REPRODUCTIVE TOXICITY (DART)
9.7.1. Overview
9.7.2. Developmental and reproductive toxicity (DART) Market Forecast and Analysis
10. IN VIVO TOXICOLOGY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America In Vivo Toxicology Market Overview
10.1.2 North America In Vivo Toxicology Market Forecasts and Analysis
10.1.3 North America In Vivo Toxicology Market Forecasts and Analysis - By Product
10.1.4 North America In Vivo Toxicology Market Forecasts and Analysis - By Testing type
10.1.5 North America In Vivo Toxicology Market Forecasts and Analysis - By Toxicity endpoint
10.1.6 North America In Vivo Toxicology Market Forecasts and Analysis - By Countries
10.1.6.1 United States In Vivo Toxicology Market
10.1.6.1.1 United States In Vivo Toxicology Market by Product
10.1.6.1.2 United States In Vivo Toxicology Market by Testing type
10.1.6.1.3 United States In Vivo Toxicology Market by Toxicity endpoint
10.1.6.2 Canada In Vivo Toxicology Market
10.1.6.2.1 Canada In Vivo Toxicology Market by Product
10.1.6.2.2 Canada In Vivo Toxicology Market by Testing type
10.1.6.2.3 Canada In Vivo Toxicology Market by Toxicity endpoint
10.1.6.3 Mexico In Vivo Toxicology Market
10.1.6.3.1 Mexico In Vivo Toxicology Market by Product
10.1.6.3.2 Mexico In Vivo Toxicology Market by Testing type
10.1.6.3.3 Mexico In Vivo Toxicology Market by Toxicity endpoint
10.2. EUROPE
10.2.1 Europe In Vivo Toxicology Market Overview
10.2.2 Europe In Vivo Toxicology Market Forecasts and Analysis
10.2.3 Europe In Vivo Toxicology Market Forecasts and Analysis - By Product
10.2.4 Europe In Vivo Toxicology Market Forecasts and Analysis - By Testing type
10.2.5 Europe In Vivo Toxicology Market Forecasts and Analysis - By Toxicity endpoint
10.2.6 Europe In Vivo Toxicology Market Forecasts and Analysis - By Countries
10.2.6.1 Germany In Vivo Toxicology Market
10.2.6.1.1 Germany In Vivo Toxicology Market by Product
10.2.6.1.2 Germany In Vivo Toxicology Market by Testing type
10.2.6.1.3 Germany In Vivo Toxicology Market by Toxicity endpoint
10.2.6.2 France In Vivo Toxicology Market
10.2.6.2.1 France In Vivo Toxicology Market by Product
10.2.6.2.2 France In Vivo Toxicology Market by Testing type
10.2.6.2.3 France In Vivo Toxicology Market by Toxicity endpoint
10.2.6.3 Italy In Vivo Toxicology Market
10.2.6.3.1 Italy In Vivo Toxicology Market by Product
10.2.6.3.2 Italy In Vivo Toxicology Market by Testing type
10.2.6.3.3 Italy In Vivo Toxicology Market by Toxicity endpoint
10.2.6.4 Spain In Vivo Toxicology Market
10.2.6.4.1 Spain In Vivo Toxicology Market by Product
10.2.6.4.2 Spain In Vivo Toxicology Market by Testing type
10.2.6.4.3 Spain In Vivo Toxicology Market by Toxicity endpoint
10.2.6.5 United Kingdom In Vivo Toxicology Market
10.2.6.5.1 United Kingdom In Vivo Toxicology Market by Product
10.2.6.5.2 United Kingdom In Vivo Toxicology Market by Testing type
10.2.6.5.3 United Kingdom In Vivo Toxicology Market by Toxicity endpoint
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific In Vivo Toxicology Market Overview
10.3.2 Asia-Pacific In Vivo Toxicology Market Forecasts and Analysis
10.3.3 Asia-Pacific In Vivo Toxicology Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific In Vivo Toxicology Market Forecasts and Analysis - By Testing type
10.3.5 Asia-Pacific In Vivo Toxicology Market Forecasts and Analysis - By Toxicity endpoint
10.3.6 Asia-Pacific In Vivo Toxicology Market Forecasts and Analysis - By Countries
10.3.6.1 Australia In Vivo Toxicology Market
10.3.6.1.1 Australia In Vivo Toxicology Market by Product
10.3.6.1.2 Australia In Vivo Toxicology Market by Testing type
10.3.6.1.3 Australia In Vivo Toxicology Market by Toxicity endpoint
10.3.6.2 China In Vivo Toxicology Market
10.3.6.2.1 China In Vivo Toxicology Market by Product
10.3.6.2.2 China In Vivo Toxicology Market by Testing type
10.3.6.2.3 China In Vivo Toxicology Market by Toxicity endpoint
10.3.6.3 India In Vivo Toxicology Market
10.3.6.3.1 India In Vivo Toxicology Market by Product
10.3.6.3.2 India In Vivo Toxicology Market by Testing type
10.3.6.3.3 India In Vivo Toxicology Market by Toxicity endpoint
10.3.6.4 Japan In Vivo Toxicology Market
10.3.6.4.1 Japan In Vivo Toxicology Market by Product
10.3.6.4.2 Japan In Vivo Toxicology Market by Testing type
10.3.6.4.3 Japan In Vivo Toxicology Market by Toxicity endpoint
10.3.6.5 South Korea In Vivo Toxicology Market
10.3.6.5.1 South Korea In Vivo Toxicology Market by Product
10.3.6.5.2 South Korea In Vivo Toxicology Market by Testing type
10.3.6.5.3 South Korea In Vivo Toxicology Market by Toxicity endpoint
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa In Vivo Toxicology Market Overview
10.4.2 Middle East and Africa In Vivo Toxicology Market Forecasts and Analysis
10.4.3 Middle East and Africa In Vivo Toxicology Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa In Vivo Toxicology Market Forecasts and Analysis - By Testing type
10.4.5 Middle East and Africa In Vivo Toxicology Market Forecasts and Analysis - By Toxicity endpoint
10.4.6 Middle East and Africa In Vivo Toxicology Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa In Vivo Toxicology Market
10.4.6.1.1 South Africa In Vivo Toxicology Market by Product
10.4.6.1.2 South Africa In Vivo Toxicology Market by Testing type
10.4.6.1.3 South Africa In Vivo Toxicology Market by Toxicity endpoint
10.4.6.2 Saudi Arabia In Vivo Toxicology Market
10.4.6.2.1 Saudi Arabia In Vivo Toxicology Market by Product
10.4.6.2.2 Saudi Arabia In Vivo Toxicology Market by Testing type
10.4.6.2.3 Saudi Arabia In Vivo Toxicology Market by Toxicity endpoint
10.4.6.3 U.A.E In Vivo Toxicology Market
10.4.6.3.1 U.A.E In Vivo Toxicology Market by Product
10.4.6.3.2 U.A.E In Vivo Toxicology Market by Testing type
10.4.6.3.3 U.A.E In Vivo Toxicology Market by Toxicity endpoint
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America In Vivo Toxicology Market Overview
10.5.2 South and Central America In Vivo Toxicology Market Forecasts and Analysis
10.5.3 South and Central America In Vivo Toxicology Market Forecasts and Analysis - By Product
10.5.4 South and Central America In Vivo Toxicology Market Forecasts and Analysis - By Testing type
10.5.5 South and Central America In Vivo Toxicology Market Forecasts and Analysis - By Toxicity endpoint
10.5.6 South and Central America In Vivo Toxicology Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil In Vivo Toxicology Market
10.5.6.1.1 Brazil In Vivo Toxicology Market by Product
10.5.6.1.2 Brazil In Vivo Toxicology Market by Testing type
10.5.6.1.3 Brazil In Vivo Toxicology Market by Toxicity endpoint
10.5.6.2 Argentina In Vivo Toxicology Market
10.5.6.2.1 Argentina In Vivo Toxicology Market by Product
10.5.6.2.2 Argentina In Vivo Toxicology Market by Testing type
10.5.6.2.3 Argentina In Vivo Toxicology Market by Toxicity endpoint
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. IN VIVO TOXICOLOGY MARKET, KEY COMPANY PROFILES
12.1. THERMO FISHER SCIENTIFIC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. DANAHER
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CHARLES RIVER LABORATORIES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. LABCORP
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. THE JACKSON LABORATORY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. DATA SCIENCES INTERNATIONAL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ENVIGO
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. EUROFINS SCIENTIFIC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PERKINELMER
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SRI INTERNATIONAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Thermo Fisher Scientific
2. Danaher
3. Charles River Laboratories
4. Labcorp
5. The Jackson Laboratory
6. Data Sciences International
7. Envigo
8. Eurofins Scientific
9. Perkinelmer
10. SRI International
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For